Search results
We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply. More. What we do. We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements.
Syngene is a contract research, development and manufacturing organization (CRDMO) that provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods and agrochemical companies.
Biologics is one of Syngene’s core service offerings comprising integrated services across the drug discovery, development and manufacturing continuum. We are committed to incrementally adding new layers of expertise to drive continued innovation.
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical,...
Syngene International is a contract research, development and manufacturing organisation (CRDMO) serving the global pharmaceutical, biotech, nutrition, animal health, consumer goods and speciality chemical sectors.
Discover Syngene's 2024 Annual Report for insights into our advancements in drug discovery, development, and manufacturing solutions for global pharmaceutical and biotech companies.
Incorporated in 1993, Syngene is an integrated research, development, and manufacturing organization specializing in both small and large molecules. Our capabilities cater to a broad range of sectors, including global pharmaceuticals, biotechnology, nutrition, animal health, consumer goods, and specialty chemicals.
